Neoantigenics, Inc. — Form D
Neoantigenics, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-22. The offering totals $1.1M, of which $112K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-10-22
- Form: D
- Accession: 0001589704-13-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $1.1M
- Amount sold: $112K
- Remaining: $988K
- Minimum investment: $10K
- Investors: 5
- Date of first sale: 2013-10-21
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-204997
Issuer
- Name: Neoantigenics, Inc.
- CIK: 0001589704
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1000 Research Park Blvd., CHARLOTTESVILLE, VA, 22911
- Phone: (434) 984-9723
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Edward J Leary | Director | Charlottesville, VA |
| Edward J Leary | Executive Officer | Charlottesville, VA |
| Edward J Leary | Promoter | Charlottesville, VA |
| Brian A Pollok | Director | North Garden, VA |
| Brian A Pollok | Executive Officer | North Garden, VA |
| Brian A Pollok | Promoter | North Garden, VA |
| John C Herr | Director | Charlottesville, VA |
| John C Herr | Executive Officer | Charlottesville, VA |
| John C Herr | Promoter | Charlottesville, VA |
| Fred J Eshelman | Director | Wilmington, NC |
Other filings by this issuer (1)
More